Table 1.
The association between TINAGL1 and clinical characteristics in HCC tissues
| Clinicopathological features | Factors | TINAGL1low expression | TINAGL1high expression | P-value |
|---|---|---|---|---|
| Age (years) | ≤50 >50 |
15 9 |
11 3 |
0.472 |
| Gender | Male Female |
13 5 |
12 8 |
0.506 |
| TNM stage | I, II III, IV |
12 5 |
6 15 |
0.021 |
| Tumor size (cm) | ≤5 >5 |
12 4 |
8 14 |
0.025 |
| Metastasis | Yes No |
5 12 |
14 7 |
0.049 |
| AFP | ≤30 >30 |
7 8 |
9 14 |
0.743 |
Note: The P-values with significance are marked in bold.
Abbreviations: AFP, alpha fetoprotein; HCC, hepatocellular carcinoma.